These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19584462)

  • 1. Outcome of dexamethasone-cyclophosphamide pulse therapy in pemphigus: a case series.
    Kandan S; Thappa DM
    Indian J Dermatol Venereol Leprol; 2009; 75(4):373-8. PubMed ID: 19584462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
    Mahajan VK; Sharma NL; Sharma RC; Garg G
    Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone-cyclophosphamide pulse therapy in pemphigus: a review of 72 cases.
    Zivanovic D; Medenica L; Tanasilovic S; Vesic S; Skiljevic D; Tomovic M; Nikolic MM
    Am J Clin Dermatol; 2010; 11(2):123-9. PubMed ID: 20141233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: a preliminary prospective randomized controlled study.
    Parmar NV; Kanwar AJ; Minz RW; Parsad D; Vinay K; Tsuruta D; Ishii N; Hashimoto T
    Indian J Dermatol Venereol Leprol; 2013; 79(1):70-6. PubMed ID: 23254732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris.
    Sethy PK; Khandpur S; Sharma VK
    Indian J Dermatol Venereol Leprol; 2009; 75(5):476-82. PubMed ID: 19736426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone-cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders at Victoria hospital, Bangalore.
    Sacchidanand S; Hiremath NC; Natraj HV; Revathi TN; Rani S; Pradeep G; Tenneti V
    Dermatol Online J; 2003 Dec; 9(5):2. PubMed ID: 14996375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
    Mentink LF; Mackenzie MW; Tóth GG; Laseur M; Lambert FP; Veeger NJ; Cianchini G; Pavlovic MD; Jonkman MF
    Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting the duration of phase I of dexamethasone - cyclophosphamide pulse therapy.
    Nayak CS; Ray S; Thombre A; Jain M
    Indian J Dermatol Venereol Leprol; 2014; 80(4):296-9. PubMed ID: 25035352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current regimen of pulse therapy for pemphigus: minor modifications, improved results.
    Pasricha JS;
    Indian J Dermatol Venereol Leprol; 2008; 74(3):217-21. PubMed ID: 18583786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of oral cyclophosphamide with dexamethasone pulse therapy in the treatment of pemphigus vulgaris.
    Momeni AZ; Iraji F; Aminjavaheri M; Emami MR; Momeni A
    J Dermatolog Treat; 2007; 18(5):275-8. PubMed ID: 17852639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide pulses with oral prednisolone in the treatment of pemphigus: a pilot study.
    Bhat R; Sharma VK; Ramam M; Kumar A
    Dermatol Online J; 2005 Dec; 11(3):4. PubMed ID: 16409900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate and delayed complications of dexamethasone cyclophosphamide pulse (DCP) therapy.
    Jain R; Kumar B
    J Dermatol; 2003 Oct; 30(10):713-8. PubMed ID: 14684952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone cyclophosphamide pulse therapy in systemic lupus erythematosus: a case report.
    Gupta R; Gupta S; Khera V
    J Dermatolog Treat; 2009; 20(1):55-8. PubMed ID: 18618362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemphigus in North-Western Yemen: A therapeutic study of 75 cases.
    Khatri ML
    Indian J Dermatol Venereol Leprol; 2016; 82(3):359. PubMed ID: 27088959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus.
    Kanwar AJ; Kaur S; Thami GP
    Dermatology; 2002; 204(3):228-31. PubMed ID: 12037452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dexamethasone-cyclophosphamide pulse therapy in bullous autoimmune dermatoses].
    Appelhans M; Bonsmann G; Orge C; Bröcker EB
    Hautarzt; 1993 Mar; 44(3):143-7. PubMed ID: 8463094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic pemphigus treated with dexamethasone/ cyclophosphamide pulse therapy.
    Becker LR; Bastian BC; Wesselmann U; Karl S; Hamm H; Bröcker EB
    Eur J Dermatol; 1998 Dec; 8(8):551-3. PubMed ID: 9889426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus.
    Saha M; Powell AM; Bhogal B; Black MM; Groves RW
    Br J Dermatol; 2010 Apr; 162(4):790-7. PubMed ID: 19922532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of corticosteroid pulse therapy: a prospective controlled study on pemphigus patients.
    Jain R; Bali H; Sharma VK; Kumar B
    Int J Dermatol; 2005 Apr; 44(4):285-8. PubMed ID: 15811078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.